ARTICLE SUMMARY:
Demand for elective orthopedic surgeries is returning faster than companies or Wall Street expected, but they aren’t sure how much is driven by a bolus from delayed procedures or arrival of new patients, which would bode well for the longer term.
Elective procedures and consumer sentiment—two key recovery metrics for the medical device industry as it gauges the rate of return to pre-pandemic normalcy—are improving faster than expected after a disastrous, COVID-19-dominated late March and April.
